Published in Chemistry on June 03, 2013
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev (2016) 1.02
Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate. Chemistry (2014) 0.81
Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles. PLoS One (2015) 0.80
Novel delivery approaches for cancer therapeutics. J Control Release (2015) 0.79
De novo generation of singlet oxygen and ammine ligands by photoactivation of a platinum anticancer complex. Angew Chem Int Ed Engl (2013) 0.78
Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angew Chem Int Ed Engl (2016) 0.77
Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate. Inorg Chem (2016) 0.75
Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes. BMC Cancer (2016) 0.75
Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt(IV) prodrug. Chem Sci (2017) 0.75
The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer (2007) 12.38
Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene (2003) 10.74
Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev (1999) 5.63
Cisplatin nephrotoxicity: a review. Am J Med Sci (2007) 4.05
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry (1985) 3.67
Current status of platinum-based antitumor drugs. Chem Rev (1999) 3.28
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature (1999) 2.35
Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry (1983) 1.96
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc Natl Acad Sci U S A (1991) 1.79
A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew Chem Int Ed Engl (2010) 1.74
DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci U S A (1993) 1.65
DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog Nucleic Acid Res Mol Biol (2002) 1.39
X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct. Proc Natl Acad Sci U S A (2010) 1.39
Ligand-selective photodissociation from [Ru(bpy)(4AP)4]2+: a spectroscopic and computational study. Inorg Chem (2009) 1.35
Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry (1987) 1.33
DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Biochemistry (1999) 1.28
Advances in platinum chemotherapeutics. Chemistry (2010) 1.22
A potent cytotoxic photoactivated platinum complex. Proc Natl Acad Sci U S A (2007) 1.21
Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity. J Med Chem (2007) 1.12
Mechanism of ligand photodissociation in photoactivable [Ru(bpy)2L2]2+ complexes: a density functional theory study. J Am Chem Soc (2008) 1.04
Trans-platinum complexes in cancer therapy. Anticancer Agents Med Chem (2007) 1.01
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Biochemistry (2003) 1.00
195Pt NMR--theory and application. Chem Soc Rev (2006) 0.99
Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance. Chemistry (2005) 0.98
DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Biochemistry (2003) 0.97
Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2]. Dalton Trans (2010) 0.92
Photoinduced reactions of cis,trans,cis-[Pt(IV)(N3)2(OH)2(NH3)2) with 1-methylimidazole. Chemistry (2009) 0.89
Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells. Chem Res Toxicol (2012) 0.88
Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers. Chem Res Toxicol (2010) 0.88
DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand. Biochem Pharmacol (2004) 0.85
Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex. FEBS J (2006) 0.85
Decomposition pathways for the photoactivated anticancer complex cis,trans,cis-[Pt(N3)2(OH)2(NH3)2]: insights from DFT calculations. Phys Chem Chem Phys (2009) 0.85
Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. J Med Chem (2002) 0.84
Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism. Mol Cancer Ther (2012) 0.84
Synthesis, characterisation and photochemistry of Pt(IV) pyridyl azido acetato complexes. Dalton Trans (2009) 0.83
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties. J Biol Inorg Chem (2004) 0.82
Tryptophan switch for a photoactivated platinum anticancer complex. J Am Chem Soc (2012) 0.82
Kinetics of binding properties of 5'-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis. J Chromatogr B Biomed Sci Appl (2000) 0.81
Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)]. J Inorg Biochem (2011) 0.79
DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects. J Biol Inorg Chem (2008) 0.78
Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP. J Inorg Biochem (2006) 0.77
A computational approach to tuning the photochemistry of platinum(IV) anticancer agents. Chemistry (2012) 0.77
Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes. Dalton Trans (2011) 0.77
Sequence-selective metalation of double-helical oligodeoxyribonucleotides with PtII, MnII, and ZnII ions. Chemistry (2003) 0.77
Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature (2012) 6.37
A double-hexameric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication. Proc Natl Acad Sci U S A (2009) 3.68
Fiber formation across the bacterial outer membrane by the chaperone/usher pathway. Cell (2008) 2.69
Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme. Proc Natl Acad Sci U S A (2005) 2.31
The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell (2009) 2.27
The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography. Science (2004) 2.18
Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J Biol Chem (2002) 2.12
Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature (2005) 2.08
New trends for metal complexes with anticancer activity. Curr Opin Chem Biol (2008) 2.06
Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci U S A (2011) 2.05
Characterization of a Mycobacterium tuberculosis proteasomal ATPase homologue. Mol Microbiol (2005) 2.00
Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles. J Physiol (2004) 1.96
Structural insights on the Mycobacterium tuberculosis proteasomal ATPase Mpa. Structure (2009) 1.96
Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate. Mol Microbiol (2006) 1.92
ATPase-dependent cooperative binding of ORC and Cdc6 to origin DNA. Nat Struct Mol Biol (2005) 1.92
Inhibitors selective for mycobacterial versus human proteasomes. Nature (2009) 1.89
Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. Biochemistry (2006) 1.88
Regio- and stereodivergent antibiotic oxidative carbocyclizations catalysed by Rieske oxygenase-like enzymes. Nat Chem (2011) 1.82
Mycobacterium tuberculosis prcBA genes encode a gated proteasome with broad oligopeptide specificity. Mol Microbiol (2006) 1.79
Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci U S A (2006) 1.77
Cryoelectron microscopy structure of purified gamma-secretase at 12 A resolution. J Mol Biol (2008) 1.75
A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew Chem Int Ed Engl (2010) 1.74
Crystal structure of the Caenorhabditis elegans apoptosome reveals an octameric assembly of CED-4. Cell (2010) 1.73
A novel protein-mineral interface. Nat Struct Biol (2003) 1.69
Role of heteromultimers in the generation of myocardial transient outward K+ currents. Circ Res (2002) 1.68
Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate. Nature (2011) 1.67
Cryo-EM structure of a helicase loading intermediate containing ORC-Cdc6-Cdt1-MCM2-7 bound to DNA. Nat Struct Mol Biol (2013) 1.66
Optically pure, water-stable metallo-helical 'flexicate' assemblies with antibiotic activity. Nat Chem (2011) 1.61
Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes (2006) 1.54
Periodic iron nanomineralization in human serum transferrin fibrils. Angew Chem Int Ed Engl (2008) 1.52
Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst (2011) 1.51
Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug Resist Updat (2005) 1.49
Metal complexes as DNA intercalators. Acc Chem Res (2011) 1.47
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov Today (2009) 1.47
Synthesis of neoglycopolymers by a combination of "click chemistry" and living radical polymerization. J Am Chem Soc (2006) 1.43
Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity. Inorg Chem (2007) 1.40
Binding-induced folding of prokaryotic ubiquitin-like protein on the Mycobacterium proteasomal ATPase targets substrates for degradation. Nat Struct Mol Biol (2010) 1.40
Organometallic half-sandwich iridium anticancer complexes. J Med Chem (2011) 1.40
"Depupylation" of prokaryotic ubiquitin-like protein from mycobacterial proteasome substrates. Mol Cell (2010) 1.37
Concordant expression of KChIP2 mRNA, protein and transient outward current throughout the canine ventricle. J Physiol (2003) 1.36
Ligand-selective photodissociation from [Ru(bpy)(4AP)4]2+: a spectroscopic and computational study. Inorg Chem (2009) 1.35
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem Commun (Camb) (2005) 1.34
DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair. J Biol Chem (2002) 1.28
Zinc(II) complexes of constrained antiviral macrocycles. Dalton Trans (2012) 1.28
Elucidation of the Streptomyces coelicolor pathway to 2-undecylpyrrole, a key intermediate in undecylprodiginine and streptorubin B biosynthesis. Chem Biol (2008) 1.27
Structure and dynamics of metallomacrocycles: recognition of zinc xylyl-bicyclam by an HIV coreceptor. J Am Chem Soc (2002) 1.26
Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. J Am Chem Soc (2002) 1.26
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. Biochemistry (2003) 1.25
The architecture of the DNA replication origin recognition complex in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2008) 1.25
Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J (2004) 1.24
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity. Inorg Chem (2006) 1.22
Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res (2007) 1.22
A potent cytotoxic photoactivated platinum complex. Proc Natl Acad Sci U S A (2007) 1.21
AcsD catalyzes enantioselective citrate desymmetrization in siderophore biosynthesis. Nat Chem Biol (2009) 1.21
Exploration of the medical periodic table: towards new targets. Chem Commun (Camb) (2013) 1.18
Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms. J Am Chem Soc (2003) 1.18
How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole. J Inorg Biochem (2012) 1.17
Protein secretion in the absence of ATP: the autotransporter, two-partner secretion and chaperone/usher pathways of gram-negative bacteria (review). Mol Membr Biol (2005) 1.17
Cytochrome P450–catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis. Nat Chem Biol (2012) 1.17
2-Alkyl-4-hydroxymethylfuran-3-carboxylic acids, antibiotic production inducers discovered by Streptomyces coelicolor genome mining. Proc Natl Acad Sci U S A (2008) 1.16
Quaternary organization of a phytochrome dimer as revealed by cryoelectron microscopy. Proc Natl Acad Sci U S A (2010) 1.14
Evidence for conservation of architecture and physical properties of Omp85-like proteins throughout evolution. Proc Natl Acad Sci U S A (2004) 1.14
Oligomeric state of the Escherichia coli metal transporter YiiP. J Biol Chem (2004) 1.14
Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2013) 1.13
Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. J Clin Endocrinol Metab (2014) 1.13
Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Updat (2002) 1.13
Combined theoretical and computational study of interstrand DNA guanine-guanine cross-linking by trans-[Pt(pyridine)2] derived from the photoactivated prodrug trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2]. Inorg Chem (2012) 1.11
Configurationally restricted bismacrocyclic CXCR4 receptor antagonists. J Med Chem (2006) 1.10
Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents. Chem Asian J (2008) 1.10
New bis(benzimidazole) cations for threading through dibenzo-24-crown-8. Org Lett (2007) 1.10
Structure of the oligosaccharyl transferase complex at 12 A resolution. Structure (2008) 1.10
Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. Dalton Trans (2009) 1.10
Multiple bacteria encode metallothioneins and SmtA-like zinc fingers. Mol Microbiol (2002) 1.09
Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Chemistry (2003) 1.09
Interdomain zinc site on human albumin. Proc Natl Acad Sci U S A (2003) 1.08
Photoactivatable platinum complexes. Anticancer Agents Med Chem (2007) 1.08
Synergistic anion and metal binding to the ferric ion-binding protein from Neisseria gonorrhoeae. J Biol Chem (2002) 1.08
Cyclam complexes and their applications in medicine. Chem Soc Rev (2004) 1.07
Experimental and theoretical 17O NMR study of the influence of hydrogen-bonding on C=O and O-H oxygens in carboxylic solids. J Phys Chem A (2006) 1.07
DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. Nucleic Acids Res (2003) 1.06
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. J Med Chem (2006) 1.06
Cdc6-induced conformational changes in ORC bound to origin DNA revealed by cryo-electron microscopy. Structure (2012) 1.06